RICO “Expressly Authorizes” Federal Stays of Mass No-Fault Collection Suits Under the Anti-Injunction Act

I. Introduction

Government Employees Insurance Company and three subsidiaries (collectively, “GEICO”) brought a federal action in the Eastern District of New York against B Hargav Patel, MD and affiliated entities (collectively, “Defendants”) alleging a broad fraud scheme exploiting New York’s no-fault automobile insurance system. GEICO pleaded civil RICO claims and state-law theories (fraud and unjust enrichment), seeking (i) repayment of allegedly fraudulent amounts already paid and (ii) a declaratory judgment that it owes nothing on pending, unpaid claims.

After GEICO sued federally, Defendants filed more than 600 separate no-fault “collection” matters in New York state courts and arbitration forums, seeking over $2 million. GEICO moved for a preliminary injunction to (a) stay the pending proceedings and (b) bar new filings until the federal RICO case is resolved. The district court granted that relief. On appeal, the Second Circuit affirmed.

Core issues on appeal: (1) whether GEICO showed irreparable harm and satisfied the preliminary injunction standard; and (2) whether the injunction unlawfully interfered with state proceedings under the Anti-Injunction Act, 28 U.S.C. § 2283.

II. Summary of the Opinion

The Second Circuit affirmed the preliminary injunction. It held that the district court did not abuse its discretion in finding:

  • Irreparable harm based on (i) a significant risk of inconsistent judgments and (ii) the risk that Defendants’ alleged “global” fraud would be obscured if GEICO had to litigate defenses piecemeal across hundreds of narrow, expedited matters—especially given the potential preclusive effect of state judgments and arbitral awards.
  • Serious questions going to the merits, supported by pleadings and motion submissions.
  • A balance of hardships tipping decidedly toward GEICO, because Defendants’ harm was primarily a delay in payment (remediable later), while GEICO risked non-remediable impairment of its ability to obtain full relief.
  • The injunction served the public interest in combating no-fault insurance fraud and preventing the no-fault system from being used to “monetize” complex alleged schemes through fragmented proceedings.

On the Anti-Injunction Act, the panel—following State Farm Mutual Automobile Insurance Company v. Tri-Borough NY Medical Practice, P.C., 120 F.4th 59 (2d Cir. 2024)—held the injunction fit within the Act’s “expressly authorized by Act of Congress” exception because RICO authorizes federal courts to issue “appropriate orders” to prevent and restrain RICO violations. Judge Park concurred in the judgment but criticized State Farm’s Anti-Injunction Act reasoning and urged narrow application.

III. Analysis

A. Precedents Cited (and How They Shape the Decision)

1. New York no-fault framework and its litigation posture

  • Med. Soc'y of N.Y. v. Serio, 100 N.Y.2d 854 (2003) and State Farm Mut. Auto. Ins. Co. v. Mallela, 372 F.3d 500 (2d Cir. 2004): Used to describe the no-fault scheme as supplanting most tort litigation and emphasizing its purpose—rapid, predictable compensation. This framing matters because the same speed/efficiency features (short deadlines, streamlined procedures) also make the system ill-suited to adjudicate complex, aggregated fraud allegations claim-by-claim.
  • Gov't Emps. Ins. Co. v. Mayzenberg, 121 F.4th 404 (2d Cir. 2024) and the New York Court of Appeals’ answer, Gov't Emps. Ins. Co. v. Mayzenberg, --- N.E.3d ---, 2025 WL 3259882 (Nov. 24, 2025): Cited for no-fault timing rules and the general proposition that insurers may bring affirmative actions after paying claims and may seek declarations as to unpaid claims. The panel noted the 2025 New York decision might affect merits questions (what defenses are available), but held it did not affect this interlocutory appeal focused on injunction factors.
  • Fair Price Med. Supply Corp. v. Travelers Indem. Co., 10 N.Y.3d 556 (2008): Supports the “preclusion” regime created by strict claim-processing deadlines (insurer risks losing defenses if it misses deadlines), illustrating why insurers may resort to post-payment fraud suits—and why the posture can become complex when many claims proceed in parallel.
  • Viviane Etienne Med. Care, P.C. v. Country-Wide Ins. Co., 25 N.Y.3d 498 (2015): Explains the minimal showing in provider collection suits (receipt of billing forms and nonpayment within 30 days), reinforcing that individual suits are narrow and may not readily reveal broader fraud patterns alleged by insurers.
  • Allstate Ins. Co. v. Mun, 751 F.3d 94 (2d Cir. 2014): Key support for the proposition that no-fault arbitration is “expedited” and not well suited to “complex fraud and RICO claims.” The panel leverages this to justify why hundreds of fragmented arbitrations/lawsuits can obscure a scheme alleged to be visible only “in the aggregate.”

2. Preliminary injunction standards and “serious questions” flexibility

  • Citigroup Glob. Mkts., Inc. v. VCG Special Opportunities Master Fund Ltd., 598 F.3d 30 (2d Cir. 2010), Zervos v. Verizon N.Y., Inc., 252 F.3d 163 (2d Cir. 2001): Define abuse-of-discretion review and the “range of permissible decisions,” giving the district court room to manage complex, multi-proceeding litigation.
  • N. Am. Soccer League, LLC v. U.S. Soccer Fed'n, Inc., 883 F.3d 32 (2d Cir. 2018), Moore v. Consol. Edison Co. of N.Y., 409 F.3d 506 (2d Cir. 2005), Faiveley Transp. Malmo AB v. Wabtec Corp., 559 F.3d 110 (2d Cir. 2009): Set the familiar preliminary injunction elements and emphasize irreparable harm as the “single most important prerequisite.”
  • State Farm Mutual Automobile Insurance Company v. Tri-Borough NY Medical Practice, P.C., 120 F.4th 59 (2d Cir. 2024) (“State Farm”): The controlling analog. It approved injunctions staying many no-fault collection proceedings because fragmented proceedings could conceal a global fraud, create inconsistent outcomes, and create preclusion risks that would impair full relief in the federal RICO case. GEICO’s case is treated as materially indistinguishable.
  • St. Joseph's Hosp. Health Ctr. v. Am. Anesthesiology of Syracuse, P.C., 131 F.4th 102 (2d Cir. 2025), New York v. U.S. Dep't of Homeland Sec., 969 F.3d 42 (2d Cir. 2020), Kamerling v. Massanari, 295 F.3d 206 (2d Cir. 2002), N.Y. Pathological & X-Ray Labs., Inc. v. INS, 523 F.2d 79 (2d Cir. 1975), Brenntag Int'l Chems., Inc. v. Bank of India, 175 F.3d 245 (2d Cir. 1999): Provide the vocabulary for “actual and imminent” harm, “continuing” harm, and the inability to restore parties to the status quo absent equitable relief.
  • Renegotiation Bd. v. Bannercraft Clothing Co., 415 U.S. 1 (1974): Supplies the general rule that litigation expense alone is not irreparable harm—but the panel distinguishes it because the key harm is not cost, but impairment of the ability to litigate the alleged scheme globally and obtain full relief.
  • Register.com, Inc. v. Verio, Inc., 356 F.3d 393 (2d Cir. 2004) and Ticor Title Ins. Co. v. Cohen, 173 F.3d 63 (2d Cir. 1999): Cited to reinforce that monetary loss combined with intangible harms can be irreparable; here, the “intangible” harm is the loss of an effective forum for adjudicating systemic fraud and the risk of preclusion undermining comprehensive relief.
  • Yang v. Kosinski, 960 F.3d 119 (2d Cir. 2020) and Winter v. Nat. Res. Def. Council, Inc., 555 U.S. 7 (2008): Provide the hardship-balancing framework.
  • Katel Ltd. Liab. Co. v. AT&T Corp., 607 F.3d 60 (2d Cir. 2010): Applied to deem Defendants’ merits challenge forfeited because it was not raised below.

3. Preclusion as a driver of irreparable harm

  • Whitfield v. City of New York, 96 F.4th 504 (2d Cir. 2024), Jacobson v. Fireman's Fund Ins. Co., 111 F.3d 261 (2d Cir. 1997): Support the proposition that state judgments and arbitral determinations may have preclusive effect in federal court.
  • Migra v. Warren City Sch. Dist. Bd. of Educ., 465 U.S. 75 (1984): Reaffirms federal courts must give state judgments the same preclusive effect they would receive in the rendering state.

4. Consolidation and state-court case management

  • Berman v. Greenwood Vill. Cmty. Dev., Inc., 156 A.D.2d 326 (2d Dep't 1989): Establishes consolidation as discretionary, undermining Defendants’ “GEICO could just consolidate” response.
  • Urban Radiology, P.C. v. GEICO, 28 Misc. 3d 1230(A) (Kings Cnty. 2010), Radiology Res. Network, P.C. v. Fireman's Fund Ins. Co., 12 A.D.3d 185 (1st Dep't 2004), Poole v. Allstate Ins. Co., 20 A.D.3d 518 (2d Dep't 2005): Used to show consolidation is typically disfavored and often unwieldy for no-fault claims not arising from a common accident, strengthening GEICO’s claim that state procedures are not a realistic substitute for a federal “global” adjudication.

5. Anti-Injunction Act, All Writs Act, and federalism boundaries

  • In re Baldwin-United Corp., 770 F.2d 328 (2d Cir. 1985): Explains All Writs Act power to protect a federal court’s ability to resolve cases on the merits.
  • Smith v. Bayer Corp., 564 U.S. 299 (2011): Emphasizes the Anti-Injunction Act’s “core message” of respect for state courts and narrowness of exceptions.
  • United States v. Schurkman, 728 F.3d 129 (2d Cir. 2013): Invoked by the district court for the “in aid of jurisdiction” exception and the concept of judgments that cannot “peaceably coexist.” The panel, however, ultimately relied on the “expressly authorized” route via State Farm.
  • Atl. Coast Line R. Co. v. Bhd. of Locomotive Eng'rs, 398 U.S. 281 (1970): Cited to dismiss federalism concerns because the stayed state proceedings were filed after the federal action commenced.

6. The concurrence’s Supreme Court roadmap (and its implications)

Judge Park’s concurrence invokes a line of Supreme Court authority—Vendo Co. v. Lektro-Vend Corp., 433 U.S. 623 (1977), Mitchum v. Foster, 407 U.S. 225 (1972), Chick Kam Choo v. Exxon Corp., 486 U.S. 140 (1988), Amalgamated Clothing Workers of Am. v. Richman Bros., 348 U.S. 511 (1955), and others—to argue State Farm misread the Anti-Injunction Act’s “expressly authorized” exception. His key point is that Congress “expressly authorizes” an injunction only when the statute makes the state proceeding itself unlawful (or explicitly halts it), and that State Farm did not require the state suits to be RICO predicate acts. Nonetheless, he concurred because circuit precedent bound the panel.

B. Legal Reasoning

1. Irreparable harm: the decision’s functional core

The panel’s irreparable-harm holding is not anchored in litigation expense, but in structural litigation risk created by mass fragmentation:

  • Inconsistent outcomes: Hundreds of proceedings magnify the probability of conflicting rulings on overlapping factual questions (e.g., medical necessity, who provided treatment, whether services occurred), producing instability and strategic leverage.
  • Obscuration of the alleged scheme: The court credited the idea that a complex, patterned fraud (predetermined protocols, inflated billing, allegedly forged signatures, allegedly unlicensed providers) may only be provable “in the aggregate,” whereas no-fault collection cases typically isolate one date of service or one billed item.
  • Preclusion risk: Because state judgments and arbitral awards can bind later litigation, early losses on narrow records can foreclose (or at least substantially impair) GEICO’s ability to obtain “complete relief” in the federal action.

This moves irreparable harm away from “money spent defending cases” and toward “loss of an effective adjudicatory opportunity” and “loss of a coherent, non-precluded merits resolution.”

2. “Serious questions” and evidentiary posture

The panel used the “serious questions going to the merits” framework to accommodate the uncertainty inherent in complex RICO-fraud litigation at an early stage. It emphasized that courts may rely on pleadings and affidavits at the preliminary injunction stage, consistent with State Farm. Defendants’ merits challenge was deemed forfeited under Katel Ltd. Liab. Co. v. AT&T Corp., 607 F.3d 60 (2d Cir. 2010).

3. Hardships and the asymmetry of remedial risk

The court treated Defendants’ hardship as largely delay in collecting claimed reimbursements—remediable with later payment if they prevail—while GEICO faced a risk that later victory would be incomplete or hollow due to preclusion and the inability to adjudicate the alleged fraud comprehensively.

4. Public interest

Relying on the no-fault system’s consumer-protection goals and prior fraud-focused commentary (including Allstate Ins. Co. v. Mun, 751 F.3d 94 (2d Cir. 2014)), the court concluded the public interest favors preserving a workable pathway for insurers to litigate complex fraud allegations that the no-fault forum design does not readily absorb.

5. The Anti-Injunction Act: from “in aid of jurisdiction” to “expressly authorized”

Although the district court relied on the “in aid of jurisdiction” exception, the panel resolved the Anti-Injunction Act question via State Farm: when a federal RICO suit alleges that hundreds of state collection suits “help further” a RICO scheme, a federal injunction can fall within the Act’s “expressly authorized” exception through RICO’s remedial provision, 18 U.S.C. § 1964(a).

Practically, the decision reinforces a pathway for insurers to seek federal stays of mass no-fault collection litigation while a federal RICO action proceeds, at least where the factual pattern resembles State Farm.

C. Impact

1. Litigation strategy in no-fault/RICO disputes

  • For insurers: The opinion strengthens a playbook: file a federal RICO action, then seek to stay a provider’s wave of no-fault collections by emphasizing (i) aggregation is essential to proving the scheme, and (ii) preclusion risks can defeat complete relief.
  • For providers: Mass filing of collection suits after an insurer initiates federal fraud litigation becomes riskier; courts may treat it as a tactic that fragments adjudication and threatens inconsistent/preclusive results.

2. Expansion (and contestation) of the Anti-Injunction Act “expressly authorized” theory under RICO

The opinion entrenches State Farm as the Second Circuit’s governing rule for RICO-based stays of large volumes of state no-fault proceedings. However, Judge Park’s concurrence signals significant doctrinal vulnerability: he argues State Farm departed from Supreme Court interpretations of the Anti-Injunction Act and should be confined to “unusual circumstances.” That tension increases the chance of future en banc or Supreme Court scrutiny, and it encourages litigants to argue for narrow application based on case volume, the relationship between the state suits and alleged RICO predicate acts, and whether state suits are “baseless” versus merely disputed.

3. Doctrinal emphasis on preclusion as irreparable harm

A notable feature is the court’s willingness—at the preliminary stage—to treat uncertain future preclusion effects as a sufficient “risk” of irreparable harm. This can influence future injunction disputes beyond no-fault litigation: parties may increasingly frame irreparable harm as “loss of a full and coherent merits determination” due to issue/claim preclusion pressures created by parallel proceedings.

IV. Complex Concepts Simplified

  • No-fault benefits (New York): A system that pays medical/economic losses from auto accidents quickly without proving fault, using strict deadlines. Providers often obtain assignments and sue/arbitrate for nonpayment.
  • RICO: A federal statute allowing civil suits for injuries caused by a “pattern of racketeering activity” (often alleged via mail/wire fraud), with broad remedial powers.
  • Preliminary injunction: A temporary court order preserving the status quo while a case proceeds. The movant must show irreparable harm, merits strength (or serious questions plus a favorable hardship balance), and public interest support.
  • Irreparable harm: Harm that cannot be fixed later with money or final relief. Here, it includes the risk that fragmented litigation and preclusion prevent a court from granting complete relief even if the plaintiff ultimately wins.
  • Collateral estoppel / preclusion: Once a court (or sometimes an arbitrator) decides an issue, that decision can bind the parties in later cases, limiting relitigation even if the later forum is different (state vs. federal).
  • Anti-Injunction Act: A federal statute generally barring federal courts from stopping state-court proceedings, with narrow exceptions—most relevant here: an injunction “expressly authorized by Act of Congress.”
  • All Writs Act: A statute empowering federal courts to issue orders needed to protect their jurisdiction—subject to constraints like the Anti-Injunction Act.

V. Conclusion

GEICO v. Patel cements, for now, a Second Circuit rule with substantial practical consequences: when an insurer alleges a complex RICO-based no-fault fraud scheme, a federal court may preliminarily stay a provider’s hundreds of parallel state collection suits to prevent inconsistent outcomes, avoid preclusion traps, and ensure the alleged scheme can be adjudicated in a unified way. The decision’s Anti-Injunction Act holding depends heavily on State Farm Mutual Automobile Insurance Company v. Tri-Borough NY Medical Practice, P.C., 120 F.4th 59 (2d Cir. 2024), and Judge Park’s concurrence underscores that this foundation is contested and may be narrowed in future cases. For litigants, the opinion elevates the importance of (i) demonstrating aggregation-dependent proof, (ii) documenting the volume and procedural limitations of parallel proceedings, and (iii) framing harm in terms of impaired adjudicatory capacity and preclusion—not merely litigation cost.